[Form 4] ARGAN INC Insider Trading Activity

Argan, Inc. (AGX) reported insider activity by an officer on 10/15/2025.

Rhea-AI Filing Summary

Argan, Inc. (AGX) reported insider activity by an officer on 10/15/2025. The reporting person exercised stock options to acquire 5,235 shares at $42.31 and 4,765 shares at $33.81, then conducted an open‑market sale of 10,000 shares at an average price of $309.37.

Following these transactions, the filer reported 21,006 shares of common stock held directly. The reporting person is identified as Chief Executive Officer, Gemma.

Insider Trade Summary

Exercise and Sale: 10,000 shares ($2.71M approx. pre-tax spread)

Exercise and Sale 5 txns

Insider Collins Charles Edwin IV

Role CHIEF EXECUTIVE OFFICER, GEMMA

Sold 10,000 shs ($3.09M)

Approx. gross sale proceeds $3.09M

Approx. exercise cost $383K

Approx. pre-tax spread $2.71M

Type	Security	Shares	Price	Value
Exercise	Option to Purchase Common Stock	5,235	$42.31	$221K
Exercise	Option to Purchase Common Stock	4,765	$33.81	$161K
Exercise	Common Stock	5,235	$42.31	$221K
Exercise	Common Stock	4,765	$33.81	$161K
Sale	Common Stock	10,000	$309.37	$3.09M

Holdings After Transaction: Option to Purchase Common Stock — 34,235 contracts (Direct); Common Stock — 21,006 shares (Direct)

Footnotes (3)

1. F1. On October 15, 2025, the Reporting Person exercised the remaining portion of his stock option awarded on September 10, 2019 to purchase 5,235 shares of the Issuer's common stock at a price of $42.31 per share.
2. F2. On October 15, 2025, the Reporting Person exercised a portion of his stock option awarded on April 16, 2020 to purchase 4,765 shares of the Issuer's common stock at a price of $33.81 per share.
3. F3. On October 15, 2025, the Reporting Person sold 10,000 shares of the Issuer's common stock on the open market at an average price of $309.37 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did AGX disclose?

The officer exercised options for 5,235 shares at $42.31 and 4,765 shares at $33.81, and sold 10,000 shares at $309.37 on 10/15/2025.

How many AGX shares were sold and at what price?

The filer sold 10,000 shares at an average price of $309.37.

What is the insider’s remaining AGX share ownership?

After the transactions, the filer reported 21,006 shares held directly.

What roles does the reporting person hold at AGX?

The reporting person is an Officer, serving as Chief Executive Officer, Gemma.

When did the AGX insider transactions occur?

All reported transactions occurred on 10/15/2025.

What types of securities were involved?

Common stock acquired via option exercises and common stock sold in the open market, as reported in Form 4 Tables I and II.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/17/2025 - 09:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Collins Charles Edwin IV

(Last) (First) (Middle)

C/O ARGAN, INC.

4075 WILSON BLVD, SUITE 440

(Street)

ARLINGTON VA 22203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER, GEMMA

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		M		5,235(1)	A	$42.31	26,241	D
Common Stock	10/15/2025		M		4,765(2)	A	$33.81	31,006	D
Common Stock	10/15/2025		S		10,000(3)	D	$309.37	21,006	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$42.31	10/15/2025		M			5,235(1)	09/10/2020	09/10/2029	Common Stock	5,235	$42.31	19,500	D
Option to Purchase Common Stock	$33.81	10/15/2025		M			4,765(2)	04/16/2021	04/16/2030	Common Stock	4,765	$33.81	14,735	D

Explanation of Responses:

1. On October 15, 2025, the Reporting Person exercised the remaining portion of his stock option awarded on September 10, 2019 to purchase 5,235 shares of the Issuer's common stock at a price of $42.31 per share.

2. On October 15, 2025, the Reporting Person exercised a portion of his stock option awarded on April 16, 2020 to purchase 4,765 shares of the Issuer's common stock at a price of $33.81 per share.

3. On October 15, 2025, the Reporting Person sold 10,000 shares of the Issuer's common stock on the open market at an average price of $309.37 per share.

	/s/ Charles E. Collins IV	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.